Metabolic-Inflammatory Syndrome: Decoding the Metabolic-Immune Axis for Precision Intervention

Area of Science:

• Metabolic disorders and immunology
• Gut microbiome research
• Chronic disease mechanisms

Background:

• Metabolic-inflammatory syndrome is a significant global health issue.
• It is closely associated with conditions like diabetes, cardiovascular disease, obesity, and non-alcoholic fatty liver disease.
• The syndrome arises from metabolic pathway alterations due to nutritional stress, leading to chronic inflammation.

Purpose of the Study:

• To systematically review the mechanisms linking metabolic reprogramming to metabolic-inflammatory syndrome.
• To elucidate the role of gut microbiota in metabolic-inflammatory syndrome.
• To evaluate existing early-warning systems and propose novel therapeutic strategies targeting the metabolic-immune axis.

Main Methods:

• Systematic literature review.
• Analysis of metabolic reprogramming pathways.
• Investigation of gut microbiota influence.
• Evaluation of current diagnostic and therapeutic approaches.

Main Results:

• Metabolic reprogramming significantly drives metabolic-inflammatory syndrome.
• Gut microbiota plays a crucial role in the development and progression of the syndrome.
• Current early-warning systems require enhancement.

Conclusions:

• Understanding the metabolic-immune axis is key to addressing metabolic-inflammatory syndrome.
• Targeted therapies focusing on metabolic reprogramming and gut microbiota modulation show promise.
• Improved early detection and intervention strategies are needed for better clinical outcomes.